Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2100045492Phase 4Recruiting
Phase 4, randomised trial of remimazolam in anxiety disorder (2 arms), sponsored by The First Affiliated Hospital of Zhengzhou University. Primary endpoints: Systolic blood pressure, Diastolic blood pressure and 1 more. Started Apr 2021; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2100045492.